Looking Into The Future of Dementia – Causes and Treatments

Lori La Bey welcomes back Sharon L. Rogers, the CEO of AmyriAD Therapeutics. Sharon was previously chief of research at Eisai, where she played a leading role in developing Aricept, the top-selling Alzheimer’s medication on the market.


Who is really funding early-stage trials?

What is the difference between Pharma and Social Therapies?

Do we know how many forms of dementia there are?

What does having a complex dementia mean?

Does a change in diagnosis affect a clinical trial?

About the Domino’s Study.

Will there be a silver bullet medication for dementia in the near future?

Listen to the full episode: Alzheimer’s Speaks on Apple Podcasts